|
PIGC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.102400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.075200E-01 |
| Normal-vs-Stage2 |
6.427200E-01 |
| Normal-vs-Stage3 |
6.364800E-01 |
| Normal-vs-Stage4 |
6.727200E-01 |
| Stage1-vs-Stage2 |
2.799400E-01 |
| Stage1-vs-Stage3 |
9.201400E-01 |
| Stage1-vs-Stage4 |
8.764800E-01 |
| Stage2-vs-Stage3 |
3.569000E-01 |
| Stage2-vs-Stage4 |
4.276000E-01 |
| Stage3-vs-Stage4 |
9.607000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.193400E-01 |
| Normal-vs-AfricanAmerican |
8.760000E-01 |
| Normal-vs-Asian |
3.375700E-02 |
| Caucasian-vs-AfricanAmerican |
7.512600E-01 |
| Caucasian-vs-Asian |
1.206340E-02 |
| AfricanAmerican-vs-Asian |
8.589600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.440400E-01 |
| Normal-vs-Female |
5.182400E-01 |
| Male-vs-Female |
5.080400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.900200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.223800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.630800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.286600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.165400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.843800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.025800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.537400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.915600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.020200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.146800E-01 |
| Classical-VS-Follicular |
7.92010000000287E-05 |
| Classical-VS-Other |
2.846400E-01 |
| Classical-VS-Normal |
1.469560E-01 |
| Tall-VS-Follicular |
1.944390E-02 |
| Tall-VS-Other |
2.900400E-01 |
| Tall-VS-Normal |
2.243400E-01 |
| Follicular-VS-Other |
8.017400E-01 |
| Follicular-VS-Normal |
1.329640E-01 |
| Other-VS-Normal |
6.267600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.225800E-01 |
| Normal-vs-N1 |
9.652000E-01 |
| N0-vs-N1 |
8.949200E-01 |
|
|
